At Genomenon, our mission to curate the entire human genome is the driving force behind everything we do. Today, we’re proud to announce a significant milestone in our journey: the acquisition of the Clinical Knowledgebase (CKB) from The Jackson Laboratory.

CKB is a leading curated variant database for interpreting complex cancer genomic profiles, and its expertise in cancer genomics is unmatched.

This acquisition is a game-changer for clinicians and researchers. CKB provides critical insights into the genetic mechanisms driving cancer, enabling clinicians to develop targeted treatments and improve patient outcomes. By combining CKB’s expertise with our own curation of the germline clinical exome, we’ll offer an unparalleled understanding of the human genome.

I’m delighted to welcome the talented and dedicated CKB team to the Genomenon family. Their passion for advancing discoveries in diagnosing and treating cancer perfectly aligns with our mission. Together, we’ll accelerate progress in precision medicine and improve patient outcomes.

I want to express my gratitude to our customers, partners, and investors who share our vision and support our mission. Curating the human genome is an ambitious goal, but with this acquisition, we’re one step closer to achieving it.

The official press release announcing the acquisition can be found here.